Biogen Buys Apellis for $5.6B to Expand Kidney Drugs
Original Report
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding its treatments in immunology and rare diseases in...
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding its treatments in immunology and rare diseases in one of the company’s largest-ever acquisitions. (Source: Bloomberg)
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
‘Liberation day’ one year later: What Trump’s tariffs are costing America
U.S. home builders and car manufacturers are taking a hit. Tariffs haven’t slashed the federal debt as promised.
Walmart-owned Sam's Club raises its annual membership fee to $60
Sam's Club is hiking membership fees as its annual sales and membership grow and as high gas prices call attention to one of its key perks.
Iran's war propaganda homes in on Trump with Lego memes
Iranian propaganda is also homing in on the war's destabilizing impact on the global economy and energy prices, which have shot up in the U.S.
Just in time for Easter: Egg prices tumbled 70%, and here’s how people responded
Cal-Maine’s stock jumped after a big earnings beat, despite a 70% drop in the price of conventional white eggs.